Precision cancer treatments, a form of personalized medicine, have been heralded as the future of oncology. Treating patients based on their specific cancer subgroup not only tends to result in better survival outcomes, it also spares some people from the grueling side-effects of broad stroke chemotherapy drugs.
While innovative cancer drugs are often in the scientific spotlight, these treatments are redundant without suitable and accessible companion diagnostics....